Skip to content
Study details
Enrolling now

Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy

Mayo Clinic
NCT IDNCT07073794ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

38

Study length

about 3 years

Ages

18+

Sex

Male only

Locations

1 site in FL

What this study is about

This trial is testing whether cancer therapy given at home is safe and effective for Black men with locally advanced, biochemically recurrent or metastatic prostate cancer compared to cancer therapy given in a clinic. The goal is to see if home-based care improves patient satisfaction and reduces distress while maintaining treatment effectiveness.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Health Care Delivery
  • 2.Questionnaire Administration
  • 3.Take Cancer Therapeutic Procedure

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Incidence of grade 3+ adverse events (AEs)

Secondary: Patient-reported function and global health status/quality of life, Patient-reported symptoms as measured by Functional Assessment of Cancer Therapy General Population 5 (FACT GP5), Patient-reported symptoms as measured by Patient Reported Outcomes (PRO)-CTCAE